Another Phase III Study Supports Avastin Expansion To Ovarian Cancer
Adding bevacizumab to chemo in first-line and maintenance therapy gives an undisclosed benefit in progression-free survival.
Adding bevacizumab to chemo in first-line and maintenance therapy gives an undisclosed benefit in progression-free survival.